All but one site were shared by the two transcriptional regulators, again suggesting: (1) incidental inclusion of NKX3-1; and, (2) more importantly, the disruption of PDX1 binding to (Supplementary Fig. 10), and altered regulation of expression from, the INS locus in insulinomas. The gene discussed is PDX1; the disease is pancreatic insulinoma.